\n
1972\n<\/h3>\n
Concept of gene therapy considered as a form of treatment in the journal Science<\/em><\/p>\n <\/div>\n<\/div>\n\n\n
\n
1984\n<\/h3>\n
Dr. Gordon Vehar publishes a paper reporting successful factor VIII<\/span><\/strong> cloning<\/p>\n <\/div>\n<\/div>\n\n\n
\n
1990\n<\/h3>\n
First gene therapy trial in humans<\/p>\n <\/div>\n<\/div>\n\n
\n
\n
1999\n<\/h3>\n
Lessons learned regarding risks related to potential for severe immune response in early gene therapy trial with non-adeno associated virus(non-AAV) vector<\/span><\/strong><\/p>\n <\/div>\n<\/div>\n\n\n
\n
2003\n<\/h3>\n
The Human Genome<\/span><\/strong> Project is completed<\/p>\n <\/div>\n<\/div>\n\n\n
\n
2003\n<\/h3>\n
China approves the first gene therapy for the treatment of head and neck cancers<\/p>\n <\/div>\n<\/div>\n\n
\n
\n
2005\n<\/h3>\n
First gene therapy trial in hemophilia B using AAV vector technology begins<\/p>\n <\/div>\n<\/div>\n\n
\n
\n
2015\n<\/h3>\n
First gene therapy trial in hemophilia A using AAV vector technology begins<\/p>\n <\/div>\n<\/div>\n\n
\n
\n
2017\n<\/h3>\n
the first gene therapy, for a genetic disease that causes blindness, is approved in the United States<\/p>\n <\/div>\n<\/div>\n\n
\n
\n
FUTURE\n<\/h3>\n
additional gene therapies are being researched<\/p>\n <\/div>\n<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n